Palatin Technologies, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
PTN Nasdaq 2836 palatin.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Palatin Technologies, Inc.

Palatin Technologies, Inc. Q4 2026 Earnings Call Summary - Sep 29th, 2026 6:30 am
Palatin Reports Fiscal Year 2026 Financial Results and Provides Business Update - Sep 28th, 2026 5:30 am
StreetWatch: A $2.9 Billion Takeover Put a Spotlight on Relentless Hunger. Palatin Technologies Is Developing the Next Generation of the Drug That Seeks to Treat It - Aug 6th, 2026 7:40 am
Palatin to Begin Trading on Nasdaq Stock Exchange - May 18th, 2026 2:00 pm
Palatin Technologies, Inc. Q3 2026 Earnings Call Summary - May 14th, 2026 6:30 am
Palatin Technologies Inc (PTN) Q3 2026 Earnings Call Highlights: Strategic Advances Amidst ... - May 13th, 2026 5:03 pm
Transcript: Palatin Techs Q3 2026 Earnings Conference Call - May 13th, 2026 9:31 am
Palatin Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update - May 13th, 2026 5:30 am
Palatin Technologies, Inc. Q2 2026 Earnings Call Summary - Feb 18th, 2026 6:30 am
Palatin Technologies Inc (PTN) Q2 2026 Earnings Call Highlights: Strategic Advances Amid Rising ... - Feb 17th, 2026 4:00 pm
Palatin Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update - Feb 17th, 2026 5:30 am
Palatin Technologies Announces Closing of Upsized $18.2 Million Public Offering with the Full Exercise of the Underwriters' Over-Allotment Option - Nov 12th, 2025 10:15 am